On May 18, 2022 Accelerating Cancer Immunotherapy Research (ACIR) has featured Immunetune’s presentation during the Cancer Immunotherapy (CIMT) (Free CIMT Whitepaper) Annual Meeting 2022 held May 10-12 in Mainz, Germany (Press release, ImmuneTune, MAY 18, 2022, View Source [SID1234614789]). At CIMT (Free CIMT Whitepaper), our CSO Jeroen van Bergen presented new preclinical results on our neoantigen cancer vaccine in combination with checkpoint inhibitors.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

ACIR’s mission is to accelerate the advancement of cancer immunotherapy by providing, free-of-charge and readily accessible on the internet, a weekly synopsis of the key advances in this fast moving and multifaceted field.